Assenagon Asset Management
ANIP icon

Assenagon Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Assenagon Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Hold
15,897
– – ﹤0.01% 926
2026
Q1 		$1.22M Sell
15,897
-73,880
-82% -$5.77M ﹤0.01% 852
2025
Q4 		$7.09M Buy
89,777
+43,449
+94% +$3.76M 0.01% 584
2025
Q3 		$4.24M Buy
46,328
+33,438
+259% +$2.73M 0.01% 647
2025
Q2 		$841K Sell
12,890
-101,728
-89% -$6.62M ﹤0.01% 946
2025
Q1 		$7.67M Sell
114,618
-196,999
-63% -$11.8M 0.01% 466
2024
Q4 		$17.2M Buy
311,617
+125,438
+67% +$7.2M 0.03% 380
2024
Q3 		$11.1M Buy
186,179
+111,613
+150% +$6.81M 0.02% 510
2024
Q2 		$4.75M Sell
74,566
-9,378
-11% -$609K 0.01% 649
2024
Q1 		$5.8M Buy
83,944
+46,008
+121% +$2.78M 0.01% 571
2023
Q4 		$2.09M Sell
37,936
-61,825
-62% -$3.4M 0.01% 906
2023
Q3 		$5.79M Buy
+99,761
New +$5.76M 0.02% 542
2021
Q4 		– Sell
-33,058
Closed -$1.08M – 1419
2021
Q3 		$1.08M Sell
33,058
-11,559
-26% -$359K ﹤0.01% 885
2021
Q2 		$1.56M Sell
44,617
-18,778
-30% -$639K 0.01% 769
2021
Q1 		$2.29M Buy
63,395
+10,332
+19% +$323K 0.01% 684
2020
Q4 		$1.54M Sell
53,063
-15,194
-22% -$435K 0.01% 588
2020
Q3 		$1.93M Sell
68,257
-74,501
-52% -$2.22M 0.01% 600
2020
Q2 		$4.62M Buy
+142,758
New +$5.12M 0.03% 343

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Assenagon Asset Management's ANIP Position: Q2 2026 in Review

Assenagon Asset Management held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 15,897 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Assenagon Asset Management first reported a position in ANIP in Q2 2020 and has held it in 18 quarters since. The position peaked at $17.2M in Q4 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Assenagon Asset Management held 15,897 shares of ANI Pharmaceuticals worth $1.32M as of Q2 2026.
  • Assenagon Asset Management left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #926 holding.
  • Assenagon Asset Management first reported a position in ANI Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • Assenagon Asset Management's ANI Pharmaceuticals position peaked at $17.2M in Q4 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.